Omkar Speciality Chemicals has received an approval for raising of funds up to an amount of Rs 125 crore, by way of a qualified institutions placement (QIP), on such terms and conditions as may be decided by the board of directors and / or committee of the board. The board of directors at their meeting held on November 13, 2014 has approved for the same.
The above will be in accordance with the provisions of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 and other applicable laws, subject to approval of the members of the company through postal ballot.
Omkar Speciality Chemicals is mainly engaged in the manufacture and sale of speciality chemicals viz., selenium compounds, iodine compounds, molybdenum compounds etc. and pharma intermediates viz., Potassium Iodate, Bismuth Ammonium Citrate, Bromoform etc.
